[1]孙洪艳.硝苯地平联合厄贝沙坦治疗糖尿病合并高血压的疗效观察[J].医学信息,2018,31(10):131-132,137.[doi:10.3969/j.issn.1006-1959.2018.10.043]
　SUN Hong-yan.Efficacy of Nifedipine Combined with Irbesartan in the Treatment of Diabetes Complicated with Hypertension[J].Journal of Medical Information,2018,31(10):131-132,137.[doi:10.3969/j.issn.1006-1959.2018.10.043]
点击复制

硝苯地平联合厄贝沙坦治疗糖尿病合并高血压的疗效观察()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年10期
页码:
131-132,137
栏目:
药物与临床
出版日期:
2018-05-15

文章信息/Info

Title:
Efficacy of Nifedipine Combined with Irbesartan in the Treatment of Diabetes Complicated with Hypertension
文章编号:
1006-1959（2018）10-0131-03
作者:
孙洪艳
东港市中心医院电诊科，辽宁 东港 118300
Author(s):
SUN Hong-yan
Department of Electrical Diagnostics,Donggang Central Hospital,Donggang 118300,Liaoning,China
关键词:
糖尿病合并高血压; 厄贝沙坦; 硝苯地平
Keywords:
Key words：Diabetes complicated with hypertension; Irbesartan; Nifedipine
分类号:
R544.1；R587.1
DOI:
10.3969/j.issn.1006-1959.2018.10.043
文献标志码:
A
摘要:
目的 探讨硝苯地平联合厄贝沙坦治疗糖尿病合并高血压的临床疗效。方法 选取2016年2月~2017年2月我院收治的糖尿病合并高血压患者共68例，按照随机数字抽签法分为对照组和观察组，每组34例。对照组给予厄贝沙坦治疗，观察组使用硝苯地平联合厄贝沙坦治疗，比较两组患者治疗总有效率、血压及24 h尿微量清蛋白指标。结果 观察组治疗总有效率为94.12%，高于对照组的67.65%，差异有统计学意义（P＜0.05）。治疗后，观察组患者的舒张压、收缩压、24 h尿微量清蛋白等指标均优于对照组，差异具有统计学意义（P＜0.05）。观察组患者的药物不良反应与对照组比较，差异无统计学意义（P＞0.05）。结论 硝苯地平联合厄贝沙坦治疗糖尿病合并高血压患者，临床疗效显著，能改善患者血压，降低24 h尿微量清蛋白，具有积极的临床推广价值。
Abstract:
Abstract：Objective To investigate the clinical efficacy of nifedipine combined with irbesartan in the treatment of diabetes complicated with hypertension.Methods A total of 68 diabetic patients with hypertension were selected from February 2016 to February 2017 in our hospital.According to the method of random number drawing,they were divided into control group and observation group with 34 cases in each group.The control group was treated with irbesartan,the observation group was treated with nifedipine combined with irbesartan.The total effective rate,blood pressure and 24 h urinary microalbumin were compared between the two groups.Results The total effective rate of the observation group was 94.12%,higher than that of the control group 67.65%,the difference was statistically significant(P<0.05).After treatment,the diastolic blood pressure,systolic blood pressure,and 24 h urine microalbumin were all better in the observation group than those in the control group,and the difference was statistically significant(P <0.05).There was no significant difference in adverse drug reactions between the observation group and the control group(P>0.05). Conclusion Nifedipine combined with irbesartan in the treatment of diabetic patients with hypertension has a significant clinical effect.It can improve the blood pressure and reduce the microalbumin in 24 h urine.It has a positive clinical value.

参考文献/References:

[1]王红太.硝苯地平联合厄贝沙坦治疗糖尿病合并高血压的疗效[J].糖尿病新世界,2016,32(2):83-84.
[2]李锴.硝苯地平联合厄贝沙坦治疗糖尿病合并高血压的效果分析[J].中国医药科学,2013,3(4):70-71.
[3]何美平.硝苯地平联合厄贝沙坦治疗糖尿病合并高血压的疗效评价[J].实用心脑肺血管病杂志,2013,21(5):84-85.
[4]郑梓强.硝苯地平联合厄贝沙坦治疗糖尿病合并高血压的效果分析[J].中国当代医药,2014,21(1):101-102.
[5]李爱民.硝苯地平联合厄贝沙坦治疗糖尿病合并高血压的研究[J].航空航天医学杂志,2014,02(6):751-752.
[6]王秀琴,张洁. 硝苯地平联合厄贝沙坦治疗糖尿病合并高血压的效果分析[J].医学信息,2016,29(2):202.
[7]刘静.74例硝苯地平联合厄贝沙坦治疗糖尿病合并高血压的疗效分析[J].中国医药指南,2014,06(14):261-262.
[8]王志英.硝苯地平联合厄贝沙坦治疗糖尿病合并高血压的疗效观察[J].临床合理用药杂志,2013,6(29):13-14.

相似文献/References:

[1]张 挺.厄贝沙坦联合美托洛尔治疗慢性充血性心衰的疗效观察[J].医学信息,2018,31(05):125.[doi:10.3969/j.issn.1006-1959.2018.05.044]
　ZHANG Ting.Efficacy of Irbesartan Combined with Metoprolol in the Treatment of Chronic Congestive Heart Failure[J].Journal of Medical Information,2018,31(10):125.[doi:10.3969/j.issn.1006-1959.2018.05.044]
[2]鲍江波.肾炎康复片联合厄贝沙坦治疗慢性肾炎蛋白尿的临床效果[J].医学信息,2020,33(13):162.[doi:10.3969/j.issn.1006-1959.2020.13.050]
　BAO Jiang-bo.Clinical Effect of Nephritis Rehabilitation Tablets Combined with Irbesartan on Proteinuria of Chronic Nephritis[J].Journal of Medical Information,2020,33(10):162.[doi:10.3969/j.issn.1006-1959.2020.13.050]
[3]徐 萌,潘琳娜,季 莹.糖尿病合并高血压患者脑微出血和脑梗塞的关系[J].医学信息,2020,33(18):83.[doi:10.3969/j.issn.1006-1959.2020.18.025]
　XU Meng,PAN Lin-na,JI Ying.The Relationship Between Cerebral Microbleeds and Cerebral Infarction in Diabetic Patients with Hypertension[J].Journal of Medical Information,2020,33(10):83.[doi:10.3969/j.issn.1006-1959.2020.18.025]
[4]王 甲,刘荣梅,杨肖沫,等.基于倾向指数匹配法的ARB类两种降压药物的成本-效果分析[J].医学信息,2023,36(16):84.[doi:10.3969/j.issn.1006-1959.2023.16.015]
　WANG Jia,LIU Rong-mei,YANG Xiao-mo,et al.Cost-effectiveness Analysis of Two Kinds of ARB Antihypertensive Drugs Based on Propensity Score Matching Method[J].Journal of Medical Information,2023,36(10):84.[doi:10.3969/j.issn.1006-1959.2023.16.015]
[5]杨启明,魏先森.诺欣妥、倍他乐克联合拜新同治疗老年高血压合并慢性心功能不全的临床研究[J].医学信息,2024,37(07):115.[doi:10.3969/j.issn.1006-1959.2024.07.022]
　YANG Qi-ming,WEI Xian-sen.A Clinical Study on the Treatment of Senile Hypertension Complicated with Chronic Cardiac Insufficiency by Ningroxinto, Betaloc Combined with Nifedipine[J].Journal of Medical Information,2024,37(10):115.[doi:10.3969/j.issn.1006-1959.2024.07.022]

更新日期/Last Update: 2018-05-15